6533b871fe1ef96bd12d2620

RESEARCH PRODUCT

Oxidative Stress and Inflammatory Biomarkers in Patients with Diabetic Foot

Sanja VujčićJelena Kotur-stevuljevićJelena VekićIva Perović-blagojevićTatjana StefanovićSanja Ilić-mijailovićBranka Koprivica UzelacSrećko BosićTamara AntonićAzra GuzonjićAna-marija MastilovićZorica MarkovićRizzo Manfredi

subject

diabetic foot; oxidative stress; diabetes mellitus; PAB; NLRNLR PAB diabetes mellitus diabetic foot oxidative stressdiabetes mellitusoxidative stressGeneral MedicinePABdiabetic footNLR

description

Background and Objectives: Diabetic foot (DF) development is driven by complex interactions of hyperglycemia, inflammation, and oxidative stress (OS). We aimed to investigate OS and inflammatory biomarkers in patients with DF and their potential to improve early diagnosis and management of DF. Materials and Methods: The prooxidant–antioxidant balance (PAB), superoxide dismutase (SOD), total oxidative status (TOS), total sulfhydryl groups (SHG), routine biochemical parameters, and complete blood count were determined in 42 patients with type-2 DM, of which 23 patients had DF, while 19 patients were without DF complications. The neutrophils-to-lymphocyte ratio (NLR) was evaluated as a biomarker of inflammation. Results: Patients with DF had significantly higher (p < 0.05) PAB levels (170 ± 33.9 U/L) compared to those without DF complications (142 ± 31.3 U/L). In addition, patients with DF had significantly reduced SOD activities (p < 0.01). NLR values were significantly higher in the DF group (median: 2.8; interquartile range: 2.0–4.3) than in the group without DF (median: 1.4; interquartile range: 1.4–2.1; p < 0.01). A positive correlation was found between the PAB and NLR index (r = 0.449; p < 0.05). The diagnostic accuracy of both PAB (AUC = 0.741; p < 0.01) and NLR (AUC = 0.760; p < 0.01) was estimated as acceptable. Conclusions: In conclusion, the development of DF is associated with enhanced OS and inflammation processes. PAB and NLR could be useful non-invasive biomarkers of DF development.

10.3390/medicina58121866https://dx.doi.org/10.3390/medicina58121866